NEW YORK (GenomeWeb News) – Patients of Asian ancestry taking the drug carbamazepine will now be advised to take a genetic test to determine whether they have a heightened risk of developing a rare but serious skin reaction, the US Food and Drug Administration said in a statement today. 
 
Carbamazepine treats epilepsy, bipolar disorder, and neuropathic pain, and is sold under the brand names Carbatrol, Equetro, and Tegretol by Shire Pharmaceuticals, Validus Pharmaceuticals, and Novartis, respectively.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.